BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 192618)

  • 1. Metabolic approaches to studies on diabetic microangiopathy.
    Waitzman MB; Colley AM; Nardelli-Olkowska K
    Diabetes; 1977 May; 26(5):510-7. PubMed ID: 192618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed metabolic dysfunctions in diabetic microthromboses and microangiopathy.
    Waitzman MB
    Metabolism; 1979 Apr; 28(4 Suppl 1):401-6. PubMed ID: 233637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of prostaglandin endoperoxides and thromboxanes in platelet aggregation.
    Samuelsson B; Hamberg M; Malmsten C; Svensson J
    Adv Prostaglandin Thromboxane Res; 1976; 2():737-46. PubMed ID: 983874
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet function and diabetes mellitus.
    Colwell JA; Halushka PV; Sarji KE; Sagel J
    Med Clin North Am; 1978 Jul; 62(4):753-66. PubMed ID: 355740
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostaglandin endoperoxides and thromboxanes: formation and effects.
    Moncada S
    Naunyn Schmiedebergs Arch Pharmacol; 1977; 297 Suppl 1():S81-4. PubMed ID: 859657
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet accumulation on collagen: drugs which inhibit arachidonic acid metabolism and affect intracellular cyclic AMP levels.
    Adams GA; Feuerstein IA
    Thromb Haemost; 1984 Aug; 52(1):45-9. PubMed ID: 6093281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered platelet function in diabetes mellitus.
    Colwell JA; Halushka PV; Sarji K; Levine J; Sagel J; Nair RM
    Diabetes; 1976; 25(2 SUPPL):826-31. PubMed ID: 823064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].
    Baluda VP; Sushkevich GN; Lukoianova TI
    Patol Fiziol Eksp Ter; 1980; (4):80-5. PubMed ID: 6251418
    [No Abstract]   [Full Text] [Related]  

  • 9. N-0164 inhibits generation of thromboxane-A2-like activity from prostaglandin endoperoxides by human platelet microsomes.
    Kulkarni PS; Eakins KE
    Prostaglandins; 1976 Sep; 12(3):465-9. PubMed ID: 968059
    [No Abstract]   [Full Text] [Related]  

  • 10. Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy.
    Schernthaner G; Sinzinger H; Silberbauer K; Freyler H; Mühlhauser I; Kaliman J
    Horm Metab Res Suppl; 1981; 11():33-43. PubMed ID: 6459282
    [No Abstract]   [Full Text] [Related]  

  • 11. Modified sensitivity of diabetic platelets to prostacyclin.
    Bonne C; Romquin N; Regnault F
    Bibl Anat; 1979; (18):98-103. PubMed ID: 227357
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased platelet adenylate cyclase activity ion diabetic patients with microangiography.
    Janka HU; Standl E; Mehnert H
    Horm Metab Res Suppl; 1981; 11():26-9. PubMed ID: 6172351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet enzyme activities in diabetes mellitus in relation to endothelial damage.
    Janka HU; Standl E; Schramm W; Mehnert H
    Diabetes; 1983 May; 32 Suppl 2():47-51. PubMed ID: 6086025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostanoids and thromboxane A2 involvement in diabetic retinopathy.
    Naveh-Floman N; Moisseiev J
    Metab Pediatr Syst Ophthalmol; 1982; 6(3-4):321-5. PubMed ID: 6764248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets and diabetic vascular disease.
    Paton RC; Passa P
    Diabete Metab; 1983 Dec; 9(4):306-12. PubMed ID: 6230270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet phosphorylase activity in the presence of activators and inhibitors of aggregation.
    Deisseroth A; Wolfe SM; Shulman NR
    Biochem Biophys Res Commun; 1970 Jul; 40(1):551-7. PubMed ID: 4318585
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
    Chen SY; Yu BJ; Liang YQ; Lin WD
    Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of action of prostaglandins on the thrombocyte-vascular wall system].
    Gabrielian ES; Akopov SE; Badzhinian SA
    Vestn Akad Med Nauk SSSR; 1984; (11):63-8. PubMed ID: 6099016
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet phosphorylase activity in the presence of activators and inhibitors of aggregation.
    Deisseroth A; Wolfe SM; Shulman NR
    Biochem Biophys Res Commun; 1970 May; 39(3):551-7. PubMed ID: 5421954
    [No Abstract]   [Full Text] [Related]  

  • 20. Release of novel prostaglandins and thromboxanes after immunological challenge of guinea pig lung.
    Dawson W; Boot JR; Cockerill AF; Mallen DN; Osborne DJ
    Nature; 1976 Aug; 262(5570):699-702. PubMed ID: 958441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.